Furthermore, we elucidated tumor clone structures and clonal evolution by integrating BCR phylogeny, genetic alterations, and transcriptional changes, demonstrating that each patient may follow a unique evolutionary path during disease progression and relapse. The gene discussed is BCR; the disease is neoplasm.